Technical Chemicals and Products, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Diagnostics manufacturer and subsidiary, Health-Mark Diagnostics, launch e-commerce program for direct consumer sales of the firm's HealthCheck home diagnostic and screening products Jan. 11, according to a TCPI release. The e-commerce service makes the firm's over-the-counter health screening, monitoring and family planning product portfolio, including diabetes, urinary tract infection, kidney and bladder disease detection kits, accessible at www.health-check.com. TCPI anticipates FDA clearance to market OTC total cholesterol screening tests and plans to submit clinical trial data on an HDL cholesterol test "soon"
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.